Westside Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $393K | Buy |
16,318
+155
| +1% | +$4.05K | 0.05% | 221 |
|
|
2026
Q1 | $454K | Sell |
16,163
-395
| -2% | -$10.5K | 0.07% | 199 |
|
|
2025
Q4 | $413K | Sell |
16,558
-107
| -0.6% | -$2.7K | 0.07% | 194 |
|
|
2025
Q3 | $428K | Sell |
16,665
-1,049
| -6% | -$25.9K | 0.07% | 198 |
|
|
2025
Q2 | $431K | Buy |
17,714
+1,205
| +7% | +$28.1K | 0.08% | 177 |
|
|
2025
Q1 | $418K | Buy |
16,509
+2,647
| +19% | +$69.3K | 0.09% | 169 |
|
|
2024
Q4 | $368K | Sell |
13,862
-146
| -1% | -$3.96K | 0.08% | 173 |
|
|
2024
Q3 | $404K | Buy |
14,008
+1,004
| +8% | +$29.3K | 0.09% | 163 |
|
|
2024
Q2 | $363K | Buy |
13,004
+854
| +7% | +$23.5K | 0.08% | 167 |
|
|
2024
Q1 | $337K | Buy |
12,150
+2,751
| +29% | +$76.3K | 0.08% | 171 |
|
|
2023
Q4 | $271K | Sell |
9,399
-2,466
| -21% | -$74.5K | 0.07% | 183 |
|
|
2023
Q3 | $394K | Buy |
11,865
+203
| +2% | +$7.18K | 0.11% | 154 |
|
|
2023
Q2 | $428K | Buy |
11,662
+102
| +0.9% | +$3.97K | 0.12% | 149 |
|
|
2023
Q1 | $484K | Buy |
11,560
+103
| +0.9% | +$4.45K | 0.14% | 131 |
|
|
2022
Q4 | $190K | Buy |
11,457
+2
| +0% | +$96 | 0.47% | 55 |
|
|
2022
Q3 | $162K | Buy |
11,455
+172
| +2% | +$8.36K | 0.39% | 61 |
|
|
2022
Q2 | $192K | Sell |
11,283
-102
| -0.9% | -$5.2K | 0.44% | 51 |
|
|
2022
Q1 | $191K | Buy |
11,385
+302
| +3% | +$15.7K | 0.42% | 54 |
|
|
2021
Q4 | $179K | Sell |
11,083
-636
| -5% | -$31.5K | 0.41% | 61 |
|
|
2021
Q3 | $159K | Buy |
11,719
+502
| +4% | +$22.2K | 0.37% | 61 |
|
|
2021
Q2 | $126K | Buy |
11,217
+3,420
| +44% | +$133K | 0.29% | 73 |
|
|
2021
Q1 | $43.7K | Sell |
7,797
-1,397
| -15% | -$49.6K | 0.12% | 118 |
|
|
2020
Q4 | $95.9K | Buy |
9,194
+1,354
| +17% | +$49.7K | 0.26% | 71 |
|
|
2020
Q3 | $44.3K | Buy |
7,840
+1,267
| +19% | +$44.4K | 0.02% | 97 |
|
|
2020
Q2 | $203 | Sell |
6,573
-340
| -5% | -$11.6K | ﹤0.01% | 237 |
|
|
2020
Q1 | $214 | Buy |
+6,913
| New | +$236K | ﹤0.01% | 231 |
|
|
2019
Q2 | $627K | Buy |
+15,260
| New | +$606K | 0.23% | 87 |
|
|
2018
Q4 | $714K | Sell |
17,232
-472
| -3% | -$19.6K | 0.26% | 69 |
|
|
2018
Q3 | $744K | Sell |
17,704
-117
| -0.7% | -$4.5K | 0.24% | 68 |
|
|
2018
Q2 | $614K | Buy |
17,821
+3
| +0% | +$103 | 0.22% | 73 |
|
|
2018
Q1 | $593K | Buy |
17,818
+2
| +0% | +$69 | 0.33% | 65 |
|
|
2017
Q4 | $616K | Buy |
17,816
+10
| +0.1% | +$341 | 0.33% | 66 |
|
|
2017
Q3 | $611K | Buy |
17,806
+2
| +0% | +$64 | 0.37% | 64 |
|
|
2017
Q2 | $564K | Sell |
17,804
-38
| -0.2% | -$1.2K | 0.37% | 69 |
|
|
2017
Q1 | $579K | Buy |
17,842
+5,917
| +50% | +$187K | 0.28% | 63 |
|
|
2016
Q4 | $371K | Buy |
+11,925
| New | +$364K | 0.25% | 61 |
|
Other funds holding PFE
Westside Investment Management's PFE Position: Q2 2026 in Review
Westside Investment Management increased its Pfizer (PFE) stake by 0.96% in Q2 2026, buying an estimated $4.05K and bringing the position to 16,318 shares worth $393K. The position accounts for 0.05% of the portfolio, ranked #221.
Westside Investment Management first reported a position in PFE in Q4 2016 and has held it in 36 quarters since. The position peaked at $744K in Q3 2018. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Westside Investment Management held 16,318 shares of Pfizer worth $393K as of Q2 2026.
- Westside Investment Management bought 155 Pfizer shares in Q2 2026, an estimated $4.05K.
- Pfizer made up 0.05% of Westside Investment Management's portfolio in Q2 2026, its #221 holding.
- Westside Investment Management first reported a position in Pfizer in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Pfizer position peaked at $744K in Q3 2018.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.